Overview
Hirotaka Nishikiori practices in Sapporo, Japan. Nishikiori is highly rated in 4 conditions, according to our data. Their top areas of expertise are Interstitial Lung Disease, Acute Interstitial Pneumonia, Idiopathic Pulmonary Fibrosis, and Pulmonary Fibrosis.
Their clinical research consists of co-authoring 36 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Acute Interstitial PneumoniaNishikiori isDistinguished. Learn about Acute Interstitial Pneumonia.
- Idiopathic Pulmonary FibrosisNishikiori isDistinguished. Learn about Idiopathic Pulmonary Fibrosis.
- Interstitial Lung DiseaseNishikiori isDistinguished. Learn about Interstitial Lung Disease.
- Pulmonary FibrosisNishikiori isDistinguished. Learn about Pulmonary Fibrosis.
- Experienced
- AsthmaNishikiori isExperienced. Learn about Asthma.
- COVID-19Nishikiori isExperienced. Learn about COVID-19.
- Hypersensitivity PneumonitisNishikiori isExperienced. Learn about Hypersensitivity Pneumonitis.
- Lung AdenocarcinomaNishikiori isExperienced. Learn about Lung Adenocarcinoma.
- Lung CancerNishikiori isExperienced. Learn about Lung Cancer.
- Non-Small Cell Lung Cancer (NSCLC)Nishikiori isExperienced. Learn about Non-Small Cell Lung Cancer (NSCLC).